Complexo Hospitalario Universitario de Santiago
Centro de atención
University of Adelaide
Adelaida, AustraliaPublicacións en colaboración con investigadores/as de University of Adelaide (12)
2023
-
Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom
Journal of Clinical Psychopharmacology, Vol. 43, Núm. 3, pp. 239-245
2021
-
Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative
Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 5, pp. 1113-1116
-
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases
The Lancet Rheumatology, Vol. 3, Núm. 10, pp. e707-e714
-
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study
The Lancet Rheumatology, Vol. 3, Núm. 12, pp. e855-e864
-
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design: MINOCA-BAT: Rationale and design
American Heart Journal, Vol. 231, pp. 96-104
-
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
Obstetrical and Gynecological Survey
2020
-
The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination
Journal of Infection, Vol. 81, Núm. 4, pp. 483-498
2019
2018
-
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
Nature Communications, Vol. 9, Núm. 1
-
Germline variation at 8q24 and prostate cancer risk in men of European ancestry
Nature Communications, Vol. 9, Núm. 1
2017
-
Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial
The Lancet Infectious Diseases, Vol. 17, Núm. 1, pp. 58-67
2012
-
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial
The Lancet Infectious Diseases, Vol. 12, Núm. 8, pp. 597-607